PYROXD1 is a flavoprotein oxidoreductase that plays a critical protective role in maintaining the catalytic activity of RTCB, the essential subunit of the tRNA ligase complex involved in tRNA splicing and the unfolded protein response 1. The protein directly binds and shields RTCB's catalytic center from oxidative inactivation under aerobic conditions by masking a conserved active-site cysteine vulnerable to oxidation 1. PYROXD1 acts as a molecular timer: NAD(P)H binding and FAD reduction allosterically enhance PYROXD1-RTCB interaction, while reoxidation of PYROXD1's FAD cofactor via its NADPH dehydrogenase activity triggers timed RTCB release, enabling subsequent guanylylation and activation 1. Additionally, PYROXD1 exhibits nuclear-cytoplasmic localization and functions as a pyridine nucleotide-dependent disulfide reductase in skeletal muscle 2. Loss-of-function mutations in PYROXD1 cause early-onset myopathy (myofibrillar myopathy type 8, LGMD-8), characterized by progressive weakness, myofibrillar disorganization, internalized nuclei, and desmin-positive inclusions 23. Disease severity correlates with genotype, with splice mutations causing reduced protein levels producing more severe presentations than missense mutations 3. Recent reports expand PYROXD1-associated disease phenotype to include connective tissue features such as osteopenia and joint hypermobility 4.